Uh Oh, We've Lost That Page!
We're sorry...
You'll probably be able to find what you want by visiting the Home page. We'll try not to let that happen again.
New Stories
-
AdvanCell enters strategic collaboration with Lilly to advance novel targeted alpha therapies
February 11, 2025 - - Latest News -
AusBiotech extends abstract deadline for April edition of Australasian Biotechnology Journal
February 11, 2025 - - Latest News -
US university joins Chimeric's CHM CDH17 clinical trial
February 11, 2025 - - Latest News -
Immunoglobulin sales drive a strong first half for CSL
February 11, 2025 - - Latest News -
Clarity expands pipeline in breast cancer with Cu-64/67 SAR-trastuzumab
February 11, 2025 - - Latest News -
PYC Therapeutics to commence human clinical trials of PYC-003 for polycystic kidney disease
February 11, 2025 - - Latest News -
Vaxxas appoints vaccine experts as it prepares for late-stage clinical trials
February 6, 2025 - - Latest News